tg-1000
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 22, 2020 (NCT04495322)
Timeline
Indications
Mechanism of action
- Influenza A virusINHIBITOR
Influenza A virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04706468 | Phase 2 | Dec 15, 2020 | Central South University, R&G Pharma Studies Co.,Ltd., TaiGen Biotechnology Co., Ltd. |
| NCT04495322 | Phase 1 | Jul 22, 2020 | Central South University, R&G Pharma Studies Co.,Ltd., TaiGen Biotechnology Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Central South University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| R&G Pharma Studies Co.,Ltd. | For profit | 2 | 0 | 2 | 2020 |
| TaiGen Biotechnology Co., Ltd. | For profit | 2 | 2 | 2 | 2020 |
3 organizations
Page 1 / 1